ATE408840T1 - Verfahren zur identifizierung von agenzien zur behandlung von anfällen, neurologischen erkrankungen, endokrinopathien und hormonalen erkrankungen - Google Patents

Verfahren zur identifizierung von agenzien zur behandlung von anfällen, neurologischen erkrankungen, endokrinopathien und hormonalen erkrankungen

Info

Publication number
ATE408840T1
ATE408840T1 AT03027613T AT03027613T ATE408840T1 AT E408840 T1 ATE408840 T1 AT E408840T1 AT 03027613 T AT03027613 T AT 03027613T AT 03027613 T AT03027613 T AT 03027613T AT E408840 T1 ATE408840 T1 AT E408840T1
Authority
AT
Austria
Prior art keywords
diseases
endocrinopathies
identifying agents
hormonal
treating seizures
Prior art date
Application number
AT03027613T
Other languages
English (en)
Inventor
Berkley Lynch
Karl Nocka
Bruno Fuks
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Application granted granted Critical
Publication of ATE408840T1 publication Critical patent/ATE408840T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT03027613T 2002-12-03 2003-12-02 Verfahren zur identifizierung von agenzien zur behandlung von anfällen, neurologischen erkrankungen, endokrinopathien und hormonalen erkrankungen ATE408840T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/308,163 US7090985B2 (en) 2002-12-03 2002-12-03 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases

Publications (1)

Publication Number Publication Date
ATE408840T1 true ATE408840T1 (de) 2008-10-15

Family

ID=32312217

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03027613T ATE408840T1 (de) 2002-12-03 2003-12-02 Verfahren zur identifizierung von agenzien zur behandlung von anfällen, neurologischen erkrankungen, endokrinopathien und hormonalen erkrankungen

Country Status (5)

Country Link
US (1) US7090985B2 (de)
EP (1) EP1426768B1 (de)
AT (1) ATE408840T1 (de)
DE (1) DE60323592D1 (de)
ES (1) ES2311667T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070135514A1 (en) * 2002-12-03 2007-06-14 Berkley Lynch Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
CA2558758C (en) * 2004-02-24 2015-06-23 Allergan, Inc. Botulinum toxin screening assays
WO2006090275A1 (en) * 2005-02-24 2006-08-31 Pfizer Limited Treatment of incontinence
DE102005046526A1 (de) * 2005-09-28 2007-04-12 Rheinische Friedrich-Wilhelms-Universität Bonn Variante des humanen SV2A-Proteins und deren Einfluss auf die Therapieantwort bei Epilepsie
US7985554B2 (en) * 2005-10-14 2011-07-26 Wisconsin Alumni Research Foundation Botulinum neurotoxin A receptor and the use thereof
US20090042835A1 (en) * 2006-06-02 2009-02-12 Davis Roger A Compositions and methods for ameliorating hyperlipidemia
AU2007254827A1 (en) * 2006-06-02 2007-12-13 San Diego State University Research Foundation Compositions and methods for ameliorating hyperlipidemia
ES2645529T3 (es) * 2006-06-15 2017-12-05 Ucb Pharma Gmbh Composición farmacéutica con efecto sinérgico anticonvulsionante
EP2051696A2 (de) * 2006-08-18 2009-04-29 Morton Grove Pharmaceuticals, Inc. Stabile flüssige levetiracetam-zusammensetzungen und verfahren
US20110212944A1 (en) * 2008-07-01 2011-09-01 Julie Liu 2-oxo-1-pyrrolidine derivatives
DK3260118T3 (da) * 2008-10-16 2021-04-19 Univ Johns Hopkins Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
JP6082250B2 (ja) * 2010-02-09 2017-02-15 ザ・ジョンズ・ホプキンス・ユニバーシティー 認知機能を改善するための方法および組成物
AU2012214303A1 (en) * 2011-02-09 2013-09-12 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2492354A1 (de) * 2011-02-23 2012-08-29 Institut National De La Recherche Agronomique (INRA) Verfahren zur Identifizierung von Verbindungen zur Behandlung lichtempfindlicher Reflexepilepsie
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142383A1 (en) 2001-04-02 2002-10-03 Merkulov Gennady V. Isolated nucleic acid molecules encoding human transport proteins
US20030009024A1 (en) 2001-06-13 2003-01-09 Millennium Pharmaceuticals, Inc. 46584, a human transporter family member and uses therefor
US20070135514A1 (en) * 2002-12-03 2007-06-14 Berkley Lynch Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases

Also Published As

Publication number Publication date
ES2311667T3 (es) 2009-02-16
US20040106147A1 (en) 2004-06-03
DE60323592D1 (de) 2008-10-30
EP1426768A2 (de) 2004-06-09
US7090985B2 (en) 2006-08-15
EP1426768A3 (de) 2006-08-30
EP1426768B1 (de) 2008-09-17

Similar Documents

Publication Publication Date Title
ATE408840T1 (de) Verfahren zur identifizierung von agenzien zur behandlung von anfällen, neurologischen erkrankungen, endokrinopathien und hormonalen erkrankungen
WO2004051222A3 (en) Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
ATE435012T1 (de) Verfahren zur behandlung von parkinson-krankheit
DE60027551D1 (de) Zusammensetzungen und verfahren zur regulierung des serumcholesterins
DE60227095D1 (de) Zusammensetzungen und verfahren zur behandlung von abgebundenem gips
DE69829336D1 (de) Vorrichtung und Verfahren zur Behandlung von Körpergewebe
DE69807538D1 (de) Vorrichtung und Verfahren zur Behandlung von Gewebe
ATE490964T1 (de) Pyrrolopyridazin-verbindungen und verwendungsverfahren dafür zur behandlung von proliferativen erkrankungen
DE60335921D1 (de) Thrombusdetektor, vorrichtung zur behandlung von thromben und verfahren dafür
ATE230617T1 (de) Verfahren und methode zur behandlung von abfällen
DE69839261D1 (de) Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen
DE69723796D1 (de) Verfahren zur Behandlung von rostfreien Stahlschlacken
DE602004010267D1 (de) Zusammensetzung mit mindestens einem substituiertem 2- 2-(4-aminophenyl)ethenyl -1-pyridinium-derivat, verfahren zur behandlung von keratinfasern damit, vorrichtung und verwendung
DE60027732D1 (de) Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE415163T1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE69906384D1 (de) Verfahren und vorrichtung zur direktreduktion von eisenerzen
ATE371453T1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE60021948D1 (de) Verfahren zur Behandlung von Kontaktlinsen
DE50213931D1 (de) Verfahren und vorrichtung zur behandlung von fehlerverdacht
DE60224650D1 (de) Vorrichtung zur behandlung von vorhof-fibrillation
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE602004010548D1 (de) Verfahren zur behandlung von tierhäuten
DE60103939D1 (de) Gehärteter Kautschuk und Verfahren zur Behandlung von gehärtetem Kautschuk
ATE287713T1 (de) Verwendung von riluzol zur behandlung multipler sklerose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee